Cogent Biosciences (COGT) Accumulated Depreciation (2017 - 2025)
Cogent Biosciences (COGT) posted quarterly Accumulated Depreciation of $8.7 million for Q4 2025, up 41.93% year-over-year from $6.1 million in Q4 2024, and up 41.93% quarter-over-quarter from $6.1 million in Q4 2024.
Cogent Biosciences (COGT) Accumulated Depreciation (2017 - 2025) Analysis & Trends
Cogent Biosciences (COGT) has reported Accumulated Depreciation for 9 consecutive years, with $8.7 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Accumulated Depreciation rose 41.93% year-over-year to $8.7 million; the TTM figure through Dec 2025 stood at $8.7 million (up 41.93% YoY), while the FY2025 annual figure was $8.7 million, up 41.93% from the prior year.
- Accumulated Depreciation grew to $8.7 million in Q4 2025 per COGT's latest filing, from $6.1 million in the prior quarter.
- Across five years, Accumulated Depreciation topped out at $8.7 million in Q4 2025 and bottomed at $559000.0 in Q4 2021.
- Historically, Accumulated Depreciation has averaged $4.1 million across 5 years, with a median of $3.7 million in 2023.
- Annual changes were most pronounced in 2021 — Accumulated Depreciation surged 35.68% — and 2023, when it soared 161.6%.
- Cogent Biosciences' Accumulated Depreciation stood at $559000.0 in 2021, then soared by 150.63% to $1.4 million in 2022, then jumped by 161.6% to $3.7 million in 2023, then soared by 66.85% to $6.1 million in 2024, then soared by 41.93% to $8.7 million in 2025.
- Business Quant data shows COGT's Accumulated Depreciation at $8.7 million in Q4 2025, $6.1 million in Q4 2024, and $3.7 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Cogent Biosciences | 6.58 Bn | 6.58 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8.68 Mn |
| Dec 31, 2024 | 6.12 Mn |
| Dec 31, 2023 | 3.67 Mn |
| Dec 31, 2022 | 1.40 Mn |
| Dec 31, 2021 | 559,000.00 |
| Dec 31, 2020 | 412,000.00 |
| Dec 31, 2019 | 4.63 Mn |
| Dec 31, 2018 | 3.50 Mn |
| Dec 31, 2017 | 2.18 Mn |